Aspira women's health to present at the medinvest biotech & pharma investor conference

Austin, texas, march 21, 2024 (globe newswire) -- aspira women's health inc. (“aspira” or the “company”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at the medinvest biotech & pharma investor conference taking place in new york city on april 3-4, 2024. management will be available for one-on-one meetings with investors who are registered for the conference.
AWH Ratings Summary
AWH Quant Ranking